中文 | English
Return
Total: 8 , 1/1
Show Home Prev Next End page: GO
MeSH:(Cefoperazone/therapeutic use)

1.Changes in plasma levels of LPS, TNFalpha and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone.

Hui-Min WANG ; Wen-Feng CAO ; Yi-Zhi PENG ; Guang-Xia XIAO ; Xiao-Yuan YANG

Chinese Journal of Burns 2004;20(2):95-97

2.Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii.

Li-wan WANG ; Lin ZOU ; Hong-xia LI ; Tian-zhi LI

Acta Academiae Medicinae Sinicae 2014;36(2):185-188

5.Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia.

Jun Yong CHOI ; Chang Oh KIM ; Yoon Seon PARK ; Hee Jung YOON ; So Youn SHIN ; Young Keun KIM ; Myung Soo KIM ; Yeon A KIM ; Young Goo SONG ; Dongeun YONG ; Kyungwon LEE ; June Myung KIM

Yonsei Medical Journal 2006;47(1):63-69

6.Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.

Ozgur OZYILKAN ; Ulku YALCINTAS ; Sezgin BASKAN

The Korean Journal of Internal Medicine 1999;14(2):15-19

8.Allergic airway response associated with the intestinal microflora disruption induced by antibiotic therapy.

Chong-hai LIU ; Xi-qiang YANG ; Chun-hua LIU ; Yun HE ; Li-jia WANG

Chinese Journal of Pediatrics 2007;45(6):450-454

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 8 , 1/1 Show Home Prev Next End page: GO